Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Glucose of Obese Patients

StatusUnknown
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Start date: Jul 21, 2024 to Sep 4, 2024
    • Primary completion date: Aug 2024 to Sep 14, 2024
    • Study completion date: Sep 2024 to Oct 1, 2024
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Problem Formulation 1. Does herbal medicine sambiloto affect the blood glucose levels of obese sufferers? 2. Does brisk walking affect blood glucose levels in obese sufferers? 3. Does the combination of bitter herbal medicine and brisk walking have an effect on blood glucose levels in obese sufferers? 4. Is there a difference in the effectiveness between herbal bitter and brisk walking and the combination on blood glucose levels in obese sufferers? Research Objectives General Objectives : The general aim of this research is to determine the difference in effectiveness between the herbal medicine Sambiloto and brisk walking as well as the combination on the blood glucose levels of obese sufferers. Specific Objective : 1. Knowing the effect of herbal medicine Sambiloto on blood glucose in obese sufferers. 2. Knowing the effect of brisk walking on blood glucose in obese sufferers. 3. To determine the effect of the combination of herbal medicine Sambiloto and brisk walking on blood glucose levels in obese sufferers.
Trial Details
NCT Number NCT06520501
Lead Sponsor Universitas Palangka Raya
Conditions
(from sponsor)		 MeSH
Related terms Obesity
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov